Viewing Study NCT00003368


Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2026-01-27 @ 2:56 PM
Study NCT ID: NCT00003368
Status: COMPLETED
Last Update Posted: 2013-03-21
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None Small Intestine Cancer View
None Unspecified Adult Solid Tumor, Protocol Specific View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III adult Hodgkin lymphoma View
None stage IV adult Hodgkin lymphoma View
None recurrent adult Hodgkin lymphoma View
None stage III cutaneous T-cell non-Hodgkin lymphoma View
None stage IV cutaneous T-cell non-Hodgkin lymphoma View
None recurrent cutaneous T-cell non-Hodgkin lymphoma View
None small intestine lymphoma View
None unspecified adult solid tumor, protocol specific View
None stage III grade 1 follicular lymphoma View
None stage III grade 2 follicular lymphoma View
None stage III grade 3 follicular lymphoma View
None stage III adult diffuse small cleaved cell lymphoma View
None stage III adult diffuse mixed cell lymphoma View
None stage III adult diffuse large cell lymphoma View
None stage III adult immunoblastic large cell lymphoma View
None stage III adult lymphoblastic lymphoma View
None stage III adult Burkitt lymphoma View
None stage IV grade 1 follicular lymphoma View
None stage IV grade 2 follicular lymphoma View
None stage IV grade 3 follicular lymphoma View
None stage IV adult diffuse small cleaved cell lymphoma View
None stage IV adult diffuse mixed cell lymphoma View
None stage IV adult diffuse large cell lymphoma View
None stage IV adult immunoblastic large cell lymphoma View
None stage IV adult lymphoblastic lymphoma View
None stage IV adult Burkitt lymphoma View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult diffuse large cell lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent adult Burkitt lymphoma View
None stage III adult T-cell leukemia/lymphoma View
None stage IV adult T-cell leukemia/lymphoma View
None recurrent adult T-cell leukemia/lymphoma View
None primary central nervous system non-Hodgkin lymphoma View
None AIDS-related peripheral/systemic lymphoma View
None AIDS-related primary CNS lymphoma View
None intraocular lymphoma View
None stage III mantle cell lymphoma View
None stage IV mantle cell lymphoma View
None recurrent mantle cell lymphoma View
None angioimmunoblastic T-cell lymphoma View
None anaplastic large cell lymphoma View
None stage III mycosis fungoides/Sezary syndrome View
None stage IV mycosis fungoides/Sezary syndrome View
None recurrent mycosis fungoides/Sezary syndrome View
None recurrent marginal zone lymphoma View
None recurrent small lymphocytic lymphoma View
None stage III small lymphocytic lymphoma View
None stage III marginal zone lymphoma View
None stage IV small lymphocytic lymphoma View
None stage IV marginal zone lymphoma View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None nodal marginal zone B-cell lymphoma View
None splenic marginal zone lymphoma View